Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

The news came as Roche recorded a 10% increase in first-quarter revenues to CHF 16.4 billion ($17.2 billion), on strong US demand for rapid COVID-19 antigen tests, as well as the performances of ...

Desmond Claude and Wesley Yates III led the way as USC advanced in the Big Ten tournament with a double-overtime win over Rutgers.

Altadena and Pacific Palisades residents who lost their homes to fire are increasingly deciding to sell their lots, not wanting to undergo the rebuilding process.

Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech Halozyme Therapeutics , the Wall Street Journal reported on Wednesday, citing ...